Glucosaminyl (N-Acetyl) Transferase 3, Mucin Type (GCNT3) Peptide
GCNT3
Reactivity: Human
Host: Synthetic
BP, BI
-
- Target See all GCNT3 products
- GCNT3 (Glucosaminyl (N-Acetyl) Transferase 3, Mucin Type (GCNT3))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- GCNT3 peptide corresponds to 13 amino acids of GCNT3.
-
-
- Application Notes
- GCNT3 Peptide is used for blocking the activity of GCNT3 antibody . The GCNT3 antibody ships at 0.5 mg/mL and the GCNT3 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- GCNT3 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- GCNT3 (Glucosaminyl (N-Acetyl) Transferase 3, Mucin Type (GCNT3))
- Synonyms
- C2/4GnT Peptide, C24GNT Peptide, C2GNT2 Peptide, C2GNTM Peptide, GNTM Peptide, 2010013H22Rik Peptide, 2210021I22Rik Peptide, 2210401J11Rik Peptide, beta-16-N-acetylglucosaminyltransferase Peptide, dI/C2/C4GnT Peptide, c2/4gnt Peptide, c24gnt Peptide, c2gnt2 Peptide, c2gntm Peptide, gntm Peptide, glucosaminyl (N-acetyl) transferase 3, mucin type Peptide, glucosaminyl (N-acetyl) transferase 3, mucin type L homeolog Peptide, GCNT3 Peptide, Gcnt3 Peptide, gcnt3.L Peptide
- Gene ID
- 9245
- NCBI Accession
- NP_004742
- OMIM
- 4758422
- UniProt
- O95395
-
You are here:
